title: Mesh sling in an era of uncertainty: lessons learned and the way forward.
abstract: Following transvaginal mesh, synthetic slings to correct stress urinary incontinence have been put under further scrutiny. Since the recent FDA website update, we reviewed the latest developments and then reflected on the lessons learned by applying this process and the way forward.
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Chapple
authors.forename: Shlomo
authors.initials: S
authors.lastname: Raz
authors.forename: Linda
authors.initials: L
authors.lastname: Brubaker
authors.forename: Philippe E
authors.initials: PE
authors.lastname: Zimmern
mesh_terms: D035881:Compensation and Redress; D019317:Evidence-Based Medicine; D005260:Female; D005544:Forecasting; D006801:Humans; D016365:Liability, Legal; D008297:Male; D061214:Patient Safety; D018579:Patient Selection; D056887:Pelvic Organ Prolapse / Q000601:surgery*; D011183:Postoperative Complications / Q000517:prevention & control; D011474:Prosthesis Design; D012307:Risk Factors; D053825:Suburethral Slings / Q000009:adverse effects / Q000639:trends; D013526:Surgical Mesh / Q000009:adverse effects / Q000639:trends*; D016896:Treatment Outcome; D014550:Urinary Incontinence, Stress / Q000601:surgery*; D013520:Urologic Surgical Procedures / Q000009:adverse effects / Q000295:instrumentation* / Q000331:legislation & jurisprudence / Q000639:trends